Early predictors of prognosis in juvenile idiopathic arthritis: A systematic literature review

Annals of the Rheumatic Diseases

Volumn 74, Issue 11, 2015, Pages 1996-2005

  Van Dijkhuizen, E H Pieter ^a,b   Wulffraat, Nico M ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; HLA ANTIGEN; RHEUMATOID FACTOR;

ARTHROPATHY; CHILD; CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; FUNCTIONAL ASSESSMENT; GENETICS; HUMAN; IMAGE ANALYSIS; IMMUNOLOGY; JUVENILE ARTHRITIS DAMAGE INDEX; JUVENILE RHEUMATOID ARTHRITIS; LONGITUDINAL STUDY; ONSET AGE; POLYARTICULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; WALLACE CRITERIA; ADOLESCENT; ARTHRITIS, JUVENILE; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; DELAYED DIAGNOSIS; HUMANS; PROGNOSIS; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 84945207666     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205265     Document Type: Review

References (72)

1. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011;377:2138-49.
2. Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
3. Adib N, Silman A, Thomson W. Outcome following onset of juvenile idiopathic inflammatory arthritis: I. Frequency of different outcomes. Rheumatology 2005;44:995-1001.
4. Adib N, Silman A, Thomson W. Outcome following onset of juvenile idiopathic inflammatory arthritis: II. Predictors of outcome in juvenile arthritis. Rheumatology 2005;44:1002-7.
5. Ravelli A. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. Clin Exp Rheumatol 2004;22:271-5.
6. Oen K. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2002;16:347-60.
7. Foell D, Wulffraat N, Wedderburn LR, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010;303:1266-73.
8. Lovell DJ, Ruperto N, Goodman S, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.
9. Ruperto N, Lovell DJ, Quartier P, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.
10. Lovell DJ, Reiff A, Ilowite NT, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008;58:1496-504.
11. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9.
12. Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011;63:465-82.
13. De Benedetti F, Brunner HI, Ruperto N, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2385-95.
14. Anderson JJ, Wells G, Verhoeven AC, et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43:22-9.
15. Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 2003;48:1771-4.
16. Moreland LW, Bridges SL Jr. Early rheumatoid arthritis: a medical emergency? Am J Med 2001;111:498-500.
17. Mottonen T, Hannonen P, Korpela M, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894-8.
18. O'Dell JR. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 2002;46:283-5.
19. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003;21 (5 Suppl 31):S154-7.
20. Albers HM, Wessels JA, Van Der Straaten RJ, et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 2009;61:46-51.
21. Wallace CA, Giannini EH, Spalding SJ, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2012;64:2012-21.
22. Vastert SJ, De Jager W, Noordman BJ, et al. Effectiveness of first line use of recombinant IL-1RA treatment in steroid naive systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheum 2014;66:1034-43.
23. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
24. Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005;52:3554-62.
25. Wallace CA, Ravelli A, Huang B, et al. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol 2006;33:789-95.
26. Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011;63:929-36.
27. De Benedetti F, Martini A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol 1998;25:203-7.
28. Fall N, Barnes M, Thornton S, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007;56:3793-804.
29. Gattorno M, Piccini A, Lasiglie D, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008;58:1505-15.
30. ∗). Annu Rev Immunol 2009;27:621-68.
31. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
32. Viola S, Felici E, Magni-Manzoni S, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 2005;52:2092-102.
33. Ruperto N, Ravelli A, Pistorio A, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 2001;19 (4 Suppl 23):S1-9.
34. Berntson L, Nordal E, Aalto K, et al. HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis. J Rheumatol 2013;40:725-31.
35. Yao TC, Tsai YC, Huang JL. Association of RANTES promoter polymorphism with juvenile rheumatoid arthritis. Arthritis Rheum 2009;60:1173-8.
36. Oen K, Tucker L, Huber AM, et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: Results of a Canadian Multicenter, prospective inception cohort study. Arthritis Care Res 2009;61:1077-86.
37. Flato B, Hoffmann-Vold AM, Reiff A, et al. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum 2006;54:3573-82.
38. Ringold S, Seidel KD, Koepsell TD, et al. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology 2009;48:972-7.
39. Albers HM, Brinkman DMC, Kamphuis SSM, et al. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res 2010;62:204-12.
40. Fantini F, Gerloni V, Gattinara M, et al. Remission in juvenile chronic arthritis: A cohort study of 683 consecutive cases with a mean 10 year followup. J Rheumatol 2003;30:579-84.
41. Flato B, Lien G, Smerdel A, et al. Prognostic factors in juvenile rheumatoid arthritis: A case-control study revealing early predictors and outcome after 14.9 Years. J Rheumatol 2003;30:386-93.
42. Minden K, Kiessling U, Listing J, et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol 2000;27:2256-63.
43. Pelajo CF, Angeles-Han ST, Prahalad S, et al. Evaluation of the association between Hispanic ethnicity and disease activity and severity in a large cohort of patients with juvenile idiopathic arthritis. Rheumatol Int 2013;33:2549-54.
44. Flato B, Aasland A, Vinje O, et al. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 1998;25:366-75.
45. Bertilsson L, Andersson-Gare B, Fasth A, et al. A 5-year prospective population-based study of juvenile chronic arthritis: Onset, disease process, and outcome. Scand J Rheumatol 2012;41:379-82.
46. Guillaume S, Prieur AM, Coste J, et al. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000;43:1858-65.
47. Al-Matar MJ, Petty RE, Tucker LB, et al. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheum 2002;46:2708-15.
48. Oen K, Malleson PN, Cabral DA, et al. Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatology 2005;44:1115-21.
49. Hyrich KL, Lal SD, Foster HE, et al. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology 2010;49:116-22.
50. Bertilsson L, Andersson-Gare B, Fasth A, et al. Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Rheumatol 2013;40:715-24.
51. Mourao AF, Caetano-Lopes J, Costa P, et al. Tumor necrosis factor-(alpha)-308 genotypes influence inflammatory activity and TNF-(alpha) serum concentrations in children with juvenile idiopathic arthritis. J Rheumatol 2009;36:837-42.
52. Oen K, Malleson PN, Cabral DA, et al. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: Subset-specific correlations. J Rheumatol 2003;30:585-93.
53. Ruperto N, Ravelli A, Levinson JE, et al. Longterm health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol 1997;24:952-8.
54. Vivarelli M, D'Urbano LE, Insalaco A, et al. Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthitis (o-JIA); association of MIF promoter polymorphisms with response to intra-articular glucocorticoids. Clin Exp Rheumatol 2007;25:775-81.
55. Berdeli A, Ozyurek AR, Ulger Z, et al. Association of macrophage migration inhibitory factor gene-173 G/C polymorphism with prognosis in turkish children with juvenile rheumatoid arthritis. Rheumatol Int 2006;26:726-31.
56. April KT, Cavallo S, Feldman DE. Children with juvenile idiopathic arthritis: are health outcomes better for those diagnosed younger? Child Care Health Dev 2013;39:442-8.
57. Cassidy JT, Martel W. Juvenile rheumatoid arthritis: clinicoradiologic correlations. Arthritis Rheum 1977;20(2 Suppl):207-11.
58. Dale K, Paus AC, Laires K. A radiographic classification system in juvenile rheumatoid arthritis applied to the knee. Eur Radiol 1994;4:27-32.
59. Duffy CM, Arsenault L, Duffy KN, et al. The juvenile arthritis quality of life questionnaire-development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1997;24:738-46.
60. Burckhardt CS, Archenholtz B, Bjelle A. Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the Quality of Life Scale (QOLS). Scand J Rheumatol 1992;21:190-5.
61. Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993;20:475-9.
62. De Rotte MC, Luime JJ, Bulatovic M, et al. Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research? Rheumatology (Oxford) 2010;49:1200-1.
63. Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009;61:658-66.
64. Magni-Manzoni S, Malattia C, Lanni S, et al. Advances and challenges in imaging in juvenile idiopathic arthritis. Nat Rev Rheumatol 2012;8:329-36.
65. Poznanski AK, Hernandez RJ, Guire KE, et al. Carpal length in children-a useful measurement in the diagnosis of rheumatoid arthritis and some concenital malformation syndromes. Radiology 1978;129:661-8.
66. Ravelli A, Ioseliani M, Norambuena X, et al. Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 2007;56:3087-95.
67. Rossi F, Di Dia F, Galipo O, et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 2006;55:717-23.
68. Lam C, Young N, Marwaha J, et al. Revised versions of the Childhood Health Assessment Questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effect. Arthritis Rheum 2004;51:881-9.
69. Groen W, Unal E, Norgaard M, et al. Comparing different revisions of the Childhood Health Assessment Questionnaire to reduce the ceiling effect and improve score distribution: Data from a multi-center European cohort study of children with JIA. Pediatr Rheumatol Online J 2010;8:16.
70. Van Dijk M, Groen W, Moors S, et al. The Dutch translation of the revised Childhood Health Assessment Questionnaire: a preliminary study of score distribution. Clin Exp Rheumatol 2010;28:275-80.
71. Norgaard M, Thastum M, Herlin T. The relevance of using the Childhood Health Assessment Questionnaire (CHAQ) in revised versions for the assessment of juvenile idiopathic arthritis. Scand J Rheumatol 2013;42:457-64.
72. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York: Springer, 2009.